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Abstract: Structural knowledge of interactions amongst the ~ 40 proteins of the human
complement system, which is central to immune surveillance and homeostasis, is expanding due
primarily to X-ray diffraction of co-crystallized proteins. Orthogonal evidence, in solution, for the
physiological relevance of such co-crystal structures is valuable since intermolecular affinities are
generally weak-to-medium and inter-domain mobility may be important. In this current work,
Fo¨rster resonance energy transfer (FRET) was used to investigate the 10 lM KD (210 kD) complex
between the N-terminal region of the soluble complement regulator, factor H (FH1-4), and the key
activation-specific complement fragment, C3b. Using site-directed mutagenesis, seven cysteines
were introduced individually at potentially informative positions within the four CCP modules
comprising FH1-4, then used for fluorophore attachment. C3b possesses a thioester domain
featuring an internal cycloglutamyl cysteine thioester; upon hydrolysis this yields a free thiol
(Cys988) that was also fluorescently tagged. Labeled proteins were functionally active as cofactors
for cleavage of C3b to iC3b except for FH1-4(Q40C) where conjugation with the fluorophore likely
abrogated interaction with the protease, factor I. Time-resolved FRET measurements were
undertaken to explore interactions between FH1-4 and C3b in fluid phase and under near-
physiological conditions. These experiments confirmed that, as in the cocrystal structure, FH1-4
binds to C3b with CCP module 1 furthest from, and CCP module 4 closest to, the thioester
domain, placing subsequent modules of FH near to any surface to which C3b is attached. The data
do not rule out flexibility of the thioester domain relative to the remainder of the complex.
Keywords: resonance energy transfer; time-resolved fluorescence; complement system; factor H;
C3b; fluorescent protein labeling
Abbreviations: AP, alternative pathway; Ax488 etc., AlexaFluor 488 (etc.); CCP, complement control protein module; EDTA, ethylene-
diaminetetraacetic acid; FH, factor H; FH1-4 (etc.), CCP modules 1–4 of FH; FI, factor I; FRET, Fo¨rster resonance energy transfer;
NMR, nuclear magnetic resonance; PBS, phosphate buffered saline; RCA, regulators of complement activation; TED, thioester
domain.
Additional Supporting Information may be found in the online version of this article.
Grant sponsor: Wellcome Trust; Grant number: 081179.
*Correspondence to: Anita C. Jones, or Paul N. Barlow, The Joseph Black Chemistry Building, University of Edinburgh, King’s
Buildings, West Mains Road, Edinburgh EH9 3JJ, UK. E-mail: a.c.jones@ed.ac.uk or paul.barlow@ed.ac.uk
2102 PROTEIN SCIENCE 2011 VOL 20:2102—2112 Published by Wiley-Blackwell. VC 2011 The Protein Society
Introduction
The complement system is vital to immune defense
and for human health.1–3 Activated via the classical,
lectin, or alternative pathways (AP), it augments cel-
lular immunity, kills pathogens, and clears antigen–
antibody complexes, and apoptotic debris. Central to
complement is proteolytic cleavage, in plasma, of
inactive C3 yielding active C3b. C3b can attach, via a
nascent reactive thioester embedded within a thioester
domain (TED), to any nearby surfaces bearing nucleo-
philes4 whereupon it self-propagates by forming part of
a convertase (a complex of C3b plus Bb, i.e., C3b.Bb)
that cleaves C3 to generate further C3b molecules.
The antibody-independent AP5 underlies the
rapid responsiveness of complement. The AP is
switched on permanently, albeit at a low-level,
through spontaneous hydrolysis of the C3 thioester
creating C3(H2O), a structural and functional analog
of C3b. Thus C3(H2O) likewise forms a convertase
complex (C3(H2O).Bb), which also cleaves C3 to
C3b.6 The slow ubiquitous turnover of C3 to
C3(H2O) consequently leads to generation of a
trickle of potentially self-amplifying C3b on plasma-
exposed surfaces. The regulators of complement acti-
vation (RCA) protein family7 prevent C3b self-propa-
gation and, crucially, act preferentially on self-surfa-
ces. The result of this selective action is protection
of self-surfaces but not foreign ones. The latter
become targets of massive C3b autoamplification and
a rapidly escalating complement-mediated response.8
Factor H (FH) is the prominent soluble member
of the RCA family. This 155 kDa glycoprotein ( 500
mg/L in plasma)9 regulates the AP and is of para-
mount importance for protection of plasma-exposed
self-surfaces not protected by other membrane-
bound RCAs. Indeed, inadequate FH functionality,
arising from mutations or single nucleotide polymor-
phisms or from antiFH antibodies is linked to age-
related macular degeneration10 and other diseases
in which complement plays a pathogenic role.11 Fac-
tor H binds to basement membranes and cell mem-
branes via recognition of polyanions12 as well as to
C3b.13,14 It thereby suppresses C3b amplification on
self-surfaces (and in fluid phase). It consists entirely
of 20 units, each 60 residues in size15 called comple-
ment control protein modules (CCPs), short consen-
sus repeats, or sushi domains. These compactly
folded,16 disulfide-stabilized modules are arranged
end-to-end17 in a contiguous fashion, with varying
levels of inter-modular flexibility.18,19
The N-terminal four CCPs of FH (i.e., FH1-4)
are necessary and sufficient for functional properties
of FH.20–23 Recombinant FH1-4 accelerates irreversi-
ble decay of the AP bimolecular C3 convertase; it is
also a cofactor for factor I (FI) in proteolytic C3b
destruction to iC3b, which is a ligand for comple-
ment receptors 2, 3, and 4, but no longer partici-
pates in the complement cascade. These activities
depend on FH1-4 binding to C3b (KD ¼ 10 lM), and
this key interaction is therefore much studied.
Structural analysis of FH1-4 was undertaken using
nuclear magnetic resonance (NMR)24 and small-
angle X-ray scattering,25,26 while a crystal structure
of the FH1-4:C3b complex was determined (PDB
2WII)27 (see Fig. 1). According to the crystal struc-
ture, FH1-4 binds with CCP 4 closest to, and con-
tacting, the TED while CCP 1 is furthest away from
the TED. In crystals, TED is packed against C3b
both in isolated protein and when in complex with
FH1-4 (see Fig. 1), but electron microscopy suggests
partial mobility of the TED in C3b.28
An initial crystal structure29 of another complex
involving a truncated RCA fragment (of complement
receptor type 2) and a C3 fragment (C3d, equivalent
to the isolated TED) conflicted with mutagenesis
and NMR30–32 unlike a recent structure of the same
complex33 that is presumably physiologically rele-
vant. Similarly, there are varying accounts of com-
plexes between the C-terminal fragment of FH
(FH19-20) and C3d.34,26 Generally, protein–protein
complexes may be misrepresented in crystal struc-
tures because of competition between interactions
driving crystallization and those driving formation
of the biological complex.35 Orthogonal evidence
regarding the physiological relevance of the crystal-
lized FH1-4:C3b complex is therefore desirable, pref-
erably via precipitant-free solution studies. One
such approach is to measure Fo¨rster resonance
energy transfer (FRET)36 between site-specifically
conjugated fluorophores.
The thiol of nascent C3b (generated by hydroly-
sis of the isoglutamyl cysteine thioester of C3 to form
Cys988 and Glu991) provides a unique attachment
point for a maleimide-coupled fluorophore. Factor H,
on the other hand, has no free thiols hence substitu-
tion by cysteines, using site-directed mutagenesis, is
required. This is challenging since FH1-4 has eight
disulfide bonds. We have exploited the C3b thiol, and
cysteine-substitution mutagenesis, in a novel
approach to using intermolecular time-resolved
FRET (based on measurement of the fluorescence
lifetime of the donor) for distance determination
between two interacting complement proteins and
we provide orthogonal support for the physiological
relevance of the crystal structure of the FH1-4:C3b
complex but cannot exclude motion of the TED.
Results
Protein production and characterization
To maximize coverage of FH1-4 but minimize likeli-
hood of structural disruption, two residues per CCP
module at exposed positions and well away from
intermodular interfaces were selected (see Fig. 1)
for mutagenesis. Native-sequence and cysteine-sub-
stitution mutant FH1-4 proteins were produced and
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purified to homogeneity, except for FH-1-4(N154C)
that was not detected in the growth media. The C3
was purified from human plasma using standard
techniques (see Methods section) and subsequently
hydrolyzed to C3(H2O) before labeling and conver-
sion to C3b.
Figure 1. Putative locations within a C3b:FH1-4 complex of cysteine-substitution FH1-4 mutations. Positions (blue) of seven
single-cysteine substitutions within crystal structure (PDB 2WII) of FH1-4 bound to C3b (gray); TED is the domain that would
be tethered to a surface in the physiological setting via cleavage of the thioester bond involving Cys988 (indicated by red
circle). Also shown is position of the disease-linked R53H mutation that along with Q40C (after labeling with the fluorophore)
abrogated cofactor activity. Inset: Table indicates inter-atomic distances measured in the crystal structure. [Color figure can
be viewed in the online issue, which is available at wileyonlinelibrary.com.]
Figure 2. Cofactor assay of seven FH1-4 mutants. Disappearance of the a
0
-chain of C3b, and appearance of 43- and 68-kDa FI/
FH-generated proteolytic products of the a
0
-chain of iC3b, were observed in Coomassie-stained gels following SDS-PAGE. Single-
cysteine substitution FH1-4 mutants, as indicated, were labeled with Ax555 maleimide then samples incubated with FI and C3b
(10 min, 37C) prior to loading. Plasma-purified full-length FH or recombinant FH1-4 served as positive controls (þve); PBS-only as
a negative control (ve). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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Cofactor activity (for FI-catalyzed cleavage of
C3b to iC3b) is a readily measurable biological func-
tion of the recombinant native-sequence FH-1-4 pro-
tein. This activity was assayed to confirm that the
AlexaFluor555 (Ax555)-tagged adducts of the
mutated versions of FH1-4 (FH1-4Ax555) retain
native-like ability to bind C3b and recruit and acti-
vate FI, and hence are likely to be properly folded.
Fluid-phase cofactor assays were conducted for all
seven fluorescently tagged single-cysteine mutants
(see Fig. 2). In the case of FH1-4(Q40C), cofactor ac-
tivity is no longer detectable after fluorescent label-
ing, which indicates the fluorescent dye blocks a
crucial binding site; this mutant was not used for
FRET studies.
Intermolecular FRET with donor label on C3b
In preparation for intermolecular FRET experi-
ments, C3b was labeled with donor AlexaFluor 488
(Ax488) maleimide (yielding C3bAx488). The fluores-
cence decay of C3bAx488 alone (i.e., in absence of any
acceptor fluorophore) required three lifetime compo-
nents for a satisfactory fit (Table S1—Supporting
Information). The observation of several decay com-
ponents indicates that the C3b-bound Ax488 exists
in a heterogeneous microenvironment, where it is
subject to a variety of local quenching interactions.
The longest lifetime of 4.1 ns corresponds to that of
the free fluorophore in phosphate-buffered saline
(Table 1.5 in Ref. 37) indicating that  40% (A1) of
the C3b-bound Ax488 population exists in an
unquenched environment. However, the remaining
60% of the population is subject to substantial
quenching giving shorter decay components (1.4 and
0.12 ns). The average lifetime, sav, of the C3b
Ax488
donor is thus 1.87 ns (Table I). This reduction in sav
and hence in quantum yield [Eq. (2), see Methods
section] of the donor is significant, because the Fo¨r-
ster distance (R0) [Eq. (4)] depends on the donor
quantum yield [Eq. (5)]. Using the respective sav’s
and a value of 0.92 for the quantum yield of Ax488
in PBS (Table 1.5 in Ref. 37) we obtain a quantum
yield for C3bAx488 of 0.42. This leads to a reduction
in the value of R0, for energy transfer from Ax488
to Ax555, from 70 A˚ for the free donor (Table 1.6 in
Ref. 37) to 61 A˚ for the C3bAx488 donor.
Having recorded data for a 400 nM sample of
C3bAx488, FH1-4Ax555 was added to a final concen-
tration of 33 lM in the sample. The fluorescence-
decay curves (Fig. 3) of all donor-plus-acceptor (i.e.,
the C3bAx488:FH1-4Ax555) complexes were well repre-
sented as a sum of three lifetime components (Table
S1—Supporting Information), except for the com-
plex with FH1-4(S254C), which required four com-
ponents. The average lifetime of C3bAx488 in each
complex is given in Table I. From the average life-
time, the energy transfer efficiency [Eq. (3)], andT
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hence the donor-acceptor distance [Eq. (4)], for each
complex was determined, as also shown in Table I.
Modules CCP 1 and CCP 2 are distant from the
thioester domain in the FH1-4:C3b complex
Addition to C3bAx488 of three mutants in which fluo-
rescently-labeled cysteine residues lie towards the
N-terminus of FH1-4 [i.e., FH1-4(N29C)Ax555, FH1-
4(N102C)Ax555, and FH1-4(N125C)Ax555] (see Fig. 1)
each produced only marginal change in the average
overall C3bAx488 fluorescence lifetime (Fig. 3, Table
I). Indeed energy transfer efficiencies were calcu-
lated at <10%, generating inferred donor-acceptor
distances of >90 A˚. Thus while formation of
C3bAx488:FH1-4Ax555 complexes modulated subtly the
fluorescence decay of the donor fluorophore attached
to the TED of C3b (as evidenced by differences in
the lifetime components used to fit the decay
curves), it is concluded that the acceptor molecules
tethered to the three cysteine residues within CCPs
1 and 2 (i.e., Cys29, Cys102, and Cys125) are too far
from the donor label (on C3b TED) for FRET to be
reliably measured. This is consistent with distances
measured (all >93 A˚) in the crystal structure of
FH1-4:C3b (see Fig. 1).
Modules CCP3 and CCP4 are closer to the
thioester domain than CCP 1 or CCP 2
The three FH1-4Ax555:C3bAx488 complexes in
which the acceptor fluorophore was attached to ei-
ther CCP 3 [FH1-4(S199C)Ax555] or CCP 4 [(FH1-
4(N238C)Ax555 and FH1-4(S254C)Ax555)] exhibited
markedly different results to those obtained for
complexes in which CCP 1 and CCP 2 were fluores-
cently labeled (Fig. 3). Average lifetimes of C3bAx488
(Table I) were 1.5 ns for FH1-4(S199C)Ax555, 1.1 ns
for FH1-4(N238C)Ax555, and 0.5 ns for FH1-
4(S254C)Ax555 (cf. the sav for the donor-only sample
of 1.9 ns) yielding efficiencies of energy transfer of
 22 6 2%, 43 6 4%, and 74 6 1%, respectively (Ta-
ble I). These values suggest that—amongst this
set—the acceptor in FH1-4(S199C)Ax555 in CCP3 is
the furthest away from the donor, with a distance of
74–77 A˚ (reasonably consistent with 66 A˚ in the
crystal structure), followed by FH1-4(N238C)Ax555 at
63–66 A˚ (35 A˚ in the crystal structure) and FH1-
4(S254C)Ax555 at 50–52 A˚ (45 A˚ in the crystal struc-
ture), in both of which the acceptor fluorophore is
linked to residues in CCP 4.
Thus the general pattern of FRET-derived inter-
molecular distances, over the four CCPs, is consist-
ent with the orientation of C3b-bound FH1-4 in the
cocrystal structure (Fig. 1). On the other hand, the
inferred interfluorophore distance between N238 of
FH1-4 and Cys988 of C3b ( 64 A˚) is longer than
would be expected from the cocrystal structure given
that the distance between the corresponding b-car-
bons is only 35 A˚.
Intermolecular FRET with acceptor label on C3b
To cross-check intermolecular distances between C3b
TED and the four N-terminal modules of FH in a
separate experiment, the C3b component of the com-
plex was labeled with Ax647 (instead of Ax488) and
Figure 3. Time-resolved fluorescence-decay curves for C3bAx488:FH1-4Ax555 complexes. Fluorescence-decay curves for:
C3bAx488: FH1-4(N29C)Ax555, C3bAx488: FH1-4(N102C)Ax555, C3bAx488: FH1-4(N125C)Ax555, C3bAx488: FH1-4(S199C)Ax555,
C3bAx488: FH1-4(N238C)Ax555 (to exemplify quality of the fit, weighted residuals for this decay curve may be viewed in Figure
S1, Supporting Information) and C3bAx488: FH1-4(N254C)Ax555. Decays of donor only (C3bAx488) are in green, of donor/
acceptor complex, pink; instrumental response functions in gray. [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
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time-resolved fluorescence decay measurements
were conducted with FH1-4Ax555 proteins as
described earlier. Thus, in these experiments the do-
nor fluorophore, Ax555, is attached to FH1-4 and
the acceptor fluorophore is conjugated to C3b. As
expected, no significant FRET was observed in the
case of donors attached to CCPs 1 and 2 (not shown)
and so the results described from hereon relate to
the three FH1-4Ax555 proteins with donors conju-
gated to CCPs 3 and 4. Fluorescence decay curves
recorded for the donors in the absence of acceptor
(i.e., the three FH1-4Ax555 proteins alone) and in the
presence of the acceptor (i.e., three FH1-4Ax555 pro-
teins in complexes with C3bAx647) were, as before, fit-
ted as a sum of multiple discrete lifetime components
(Table S2—Supporting Information), again reflecting
the heterogeneous microenvironment of the donor fluo-
rophore. The quantum-yield-corrected R0 value for
each of the three FH1-4Ax555 donors was calculated, as
described earlier, using the quantum yield values
given in Table S2. The fluorescence lifetime, quantum
yield and R0 (for energy transfer to Ax647) of free
Ax555 are 0.3 ns, 0.1 and 51 A˚,, respectively. As shown
in Table S2, the FH1-4Ax555 R0 values are somewhat
greater than those of the free donor, with values of 56
A˚ for both FH1-4(S199C)Ax555 and FH1-4(S254C)Ax555,
and 60 A˚ for FH1-4(N238C)Ax555.
Average lifetimes were determined for FH1-
4(S199C)Ax555 to be 0.52 ns versus 0.45 ns in ab-
sence versus presence of C3bAx647 (Table I), yielding
an energy transfer efficiency of 13% (but with a
large, 610%, error) converting to a poorly defined
donor-acceptor distance of between 68 and 101 A˚;
this may be compared to the C3bAx488 measurement
(above) of 74–77 A˚ and the X-ray derived (inter b-
carbon) distance of 66 A˚. In the case of the fluores-
cence decay (Fig. 4) of the FH1-4(N238C)Ax555 sam-
ple, average lifetimes were determined to be 0.82
and 0.51 ns, in absence and presence of C3bAx647,
respectively; this equates to a FRET efficiency of 38
6 7% leading to a calculated donor-acceptor distance
in the range of 63–69 A˚ (Table I), compared to 63–66
A˚ measured above and 35 A˚ (inter b-carbon) in the
X-ray derived structure. Finally, in the case of the
FH1-4(S254C)Ax555 sample, average lifetimes were
0.54 ns (alone) versus 0.30 ns (with C3b), the energy
transfer efficiency from donor to acceptor was there-
fore 44 6 7%, which corresponds to a distance of 56–
61 A˚, compared to 50–52 A˚ measured above and 45
A˚ (inter b-carbon) according to X-ray diffraction. As
before, these results place CCP 4 closer to the thio-
ester than CCP 3 (or CCPs 1 or 2) but the inferred
distance from Asn238 to Cys988 (of C3b) is some-
what longer than that measured within the cocrystal
structure.
Discussion
Three-dimensional structures of individual protein
domains (or modules) are easily determined experi-
mentally or modeled by homology. It is less
straightforward to elucidate the spatial arrange-
ment of domains within the very large category of
inherently flexible multiple-domain proteins—exem-
plified by FH—and their numerous, potentially
transient, complexes. While FRET based on specifi-
cally positioned donor and acceptor fluorophores
has been widely employed for protein-structure
determination, its use to investigate interactions
between the difficult-to-study multiple-domain and
disulfide-rich proteins of the complement system
has received only limited attention.38,39 By using
FRET in the current work to validate the physiologi-
cal relevance of previous crystallography and EM-
based studies we have not only enhanced confidence
in these results but also explored the potential of
FRET for looking at further complexes, for which
high-resolution structural information is lacking.
Incorporation of free cysteine residues into pro-
teins that naturally contain multiple disulfides car-
ries the risk of disulfide shuffling and misfolding. In
this study, we showed that P. pastoris is a suitable
expression host for production and secretion into the
growth medium of useful quantities of a panel of sin-
gle cysteine-substitution mutants of a FH fragment
(FH1-4, with eight disulfides) with a success rate of
seven mutants obtained out of eight. All seven
Figure 4. Time-resolved fluorescence-decay curves for C3bAx647: FH1-4A555 complexes. Fluorescence decay curves for
C3bAx647: FH1-4(S199C)A555, C3bAx647: FH1-4(N238C)A555, and C3bAx647: FH1-4(N254C)A555. Decays of donor only (FH1-
4Ax555) are purple, of the donor/acceptor complex, cyan; instrumental response functions in gray. [Color figure can be viewed
in the online issue, which is available at wileyonlinelibrary.com.]
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successfully produced and purified mutants—that
are distributed over all four CCP modules and are
positioned away from intermodular interfaces—
retained significant cofactor activity for FI-catalyzed
cleavage of C3b (not shown); one of them—FH1-
4(Q40C)—lost cofactor activity when tagged with the
relatively bulky fluorescent probe, Ax555. Cofactor
activity, which likely involves binding of FH1-4 to
both C3b and FI, is one of the principal functions of
FH and is entirely contained within, and depends
upon, the structural integrity of, FH1-4. The FH1-
4(Q40C) mutant was not used for further studies; in
fact, the coordinates of the cocrystal structure, once
they became available, showed that none of the
seven replaced residues do in fact participate
directly in the crystallographic C3b-FH1-4 interface
(see Fig. 1). Hence, loss of function of FH1-4(Q40C)
was probably not because of loss of C3b binding but
more likely arose from interference between the
probe and FI. Indeed Gln40 lies on the same face of
CCP 1 as the R53H, aHUS-linked, mutation that
was recently shown to bind normally to C3b but to
have depleted cofactor activity.40 The cofactor activ-
ity of FH1-4(S254C)Ax555 was also somewhat dimin-
ished. Thus, taken together, our data support the
presence of an extended composite C3b/FH 1-4 bind-
ing site for FI lying close to the proteolytic cleavage
site within the CUB domain (Fig. 1).
Intermolecular FRET-based distances were
measured (see Figs. 3 and 4, and Table I) in the
complex of FH1-4 and C3b. Recombinant C3b was
not available but the presence of the free thiol in the
TED is serendipitous since it allows a fluorophore to
be placed at an informative position within the C3b
structure. The N-terminal (CCPs 1-4) and C-termi-
nal (CCPs 19-20) regions of FH (155 kDa) bind coop-
eratively to C3b (180 kDa) producing a 1:1 (FH:C3b)
complex with a KD ¼  1 lM (as measured by SPR).
Full-length FH and its complexes have resisted all
efforts at crystallization but the X-ray derived struc-
tures of FH1-4 in complex with C3b (KD ¼ 10 lM)27
and (separately) FH19-20 in complex with the C3d
(TED) derivative of C3b34,26 (KD ¼ 4 lM), are in-
formative. Neither of these structures have, how-
ever, been verified by orthogonal structural methods.
Indeed, there is controversy over interpretation of
the physiological relevance of protein–protein com-
plexes observed in the two independently solved
crystal structures of FH19-20:C3d, reminiscent of
more profound questions as to the relevance of
a previously solved structure of C3d and the two
N-terminal modules of complement receptor type
229,33 (a close homolog of FH). The structure of FH1-
4 with C3b27 is less controversial since it reveals a
highly extended intermolecular interface, but the
weak KD for this complex is close to what some
regard as a safe limit beyond which precipitant-
enhanced crystallographic interactions might out-
compete weaker but biologically important ones.
Indeed the orientation of FH1-4 on the C3b in this
structure is counterintuitive since, for C3b tethered
to a surface, it places the N-terminal part of FH fur-
thest from the surface and the C-terminal part (from
which extends an additional 16 modules in native
FH) very close to the surface. Therefore the use of
time-resolved FRET to measure interdomain distan-
ces in the FH1-4:C3b complex is a useful means of
validating or otherwise the crystal structure.
Our strategic placement of fluorophores on
FH1-4 allows its orientation as observed in the
crystal structure of FH1-4:C3b to be tested since
the observed orientation will place N-terminal CCP
1 furthest away from the fluorescently-tagged TED,
followed by CCP 2 and then CCP 3, with CCP 4
being closest. Our results clearly showed that fluo-
rophores on CCP 1 (attached to N29C) was beyond
the upper limit of the FRET range with respect to
the fluorophore on Cys988 of TED, while those on
CCP 2 (N102C and N125C) were at the edge of
detection; indeed the corresponding intermolecular
distances (approximated as Cb-Cb) in the crystal
complex are all >93 A˚. FRET-based estimates for
the distance between the fluorophores on CCPs 3
and 4 showed excellent agreement when comparing
the two FRET pairs used in this study. The results
are consistent with CCP 4 being closer to the TED
than CCP 3. Thus even in the absence of precipi-
tants and crystal packing forces FH1-4 bind to sur-
face-tethered C3b with the fourth module closest to
the surface. While this potentially projects subse-
quent CCPs counter intuitively into the glycocalyx,
it is nonetheless not inconsistent with other homo-
logous, small complement regulators in which the
fourth CCP (out of four CCPs in total) immediately
precedes a membrane-associating (CD55) or mem-
brane-spanning (CD46) region binding to C3b in
the same orientation.
One notable discrepancy with respect to the
crystal structure is that the donor-acceptor distances
measured for FH1-4(N238C)—  64 or  66 A˚,
depending on which FRET pair was used—were lon-
ger than those measured using S254C ( 51 or  59
A˚) while in the cocrystal structure, CCP4 and TED
are juxtaposed so that the b carbons of Asn238 and
Ser254 are just 35 and 45 A˚ away from Cys988 Cb,
respectively. It is possible, given that free rotation
has been assumed in the calculation of the Ro dis-
tances, that such discrepancies could arise from
some hindrance to the free rotation of the donor or
acceptor when attached to the cysteine. A more
interesting possibility is that the CCP3-CCP4 junc-
tion is flexible, or more likely that the TED, which
is flexibly attached to the rest of the C3b molecule
according to some electron micrographs,28 retains a
degree of mobility even in the presence of FH1-4
(see cartoon, Fig. 5).
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The currently accepted model is that full-length
FH bends back on itself via a central hinge-like
region41 and its C-terminus (FH19-20) binds to a
distinct site on the TED immediately adjacent to the
extended FH1-4 binding site (and to nearby surface-
borne glycosaminoglycans). This second interaction
with FH19-20 might further stabilize the conforma-
tion of C3b observed in the crystal structure with
FH1-4, although it might also stabilize a different
structure. The former hypothesis—in which the N-
terminal part of module 19 lies close to the C-termi-
nal region of CCP 426—could readily be tested in an
extension of our approach by using fluorophore-la-
beled P. pastoris-expressed single cysteine-substitu-
tion mutants of FH-1-4 and FH19-20 fragments in
ternary complex with C3b. Time-resolved FRET
measurements of this kind could also be performed
in physiological settings such as on a C3b-opsonized
cell surface. More generally, many protein–protein
interaction networks, for which the mammalian
complement system is a paradigm, depend on highly
coordinated sequences of domain rearrangements
and on both intramolecular and intermolecular
domain–domain recognition events. A combination of
orthogonal methods is required to study such ‘‘do-
main choreography’’ and we have proved the utility
of one such technique by successfully applying
FRET in initial estimates of interdomain distances
in proteins of the complement system.
Materials and Methods
Fluorescent probes, Alexa488 maleimide, Alexa555
maleimide, and Alexa647 maleimide were from Invi-
trogen (Molecular Probes). Complement proteins
C3b (for cofactor activities only), FI, and plasma-
purified FH were from Complement Technology
(TX). Cobra venom factor:Bb complex was a gift
from Viviana Ferreira (University of Texas).
The DNA coding for FH1-4 (residues 20–262,
numbering includes pre–pro sequence) was amplified
from full-length FH cDNA as described in Ref. 24.
N-terminal c-myc (EQKLISEEDL) and C-terminal
hexaHis- tags were introduced. The coding region of
FH1-4 was mutated to encode variants FH1-4(N29C),
FH1-4(Q40C), FH1-4(N102C), FH1-4(N125C), FH1-
4(N154C), FH1-4(S199C), FH1-4(N238C), and FH1-
4(S254C), using QuikChange site-directed mutagenesis
(Stratagene). Genes of the confirmed sequences were
expressed in the Pichia pastoris strain KM71H in
500 mL of cell culture. After an induction period of
four days, cells were pelleted, supernatant was har-
vested, and pH adjusted to 7.5.
Purifications was achieved by Ni2þ-affinity chro-
matography (HisTrap column, GE Healthcare).
Labeling with Ax555 maleimide was performed in 20
mM sodium phosphate (pH 7.0, dye:protein ratio ¼
2:1, 4 h, 25C) in the dark. Unreacted dye was
removed by buffer exchange in 5 mM Tris, pH 8.0.
Purification from nonlabeled protein was achieved
by ion-exchange chromatography using a Tricorn
MonoQ (GE Healthcare) with a linear gradient from
5 mM Tris, pH 8.0 to 5 mM Tris, pH 8.0, plus 1M
NaCl (flow-rate 2 mL/min). Elution of nonlabeled
FH1-4 occurred at 400 mM NaCl, and of labeled
FH1-4 at 600 mM NaCl. Protein concentrations were
measured using k280.
Complement component C3 was sourced from
human plasma following a method described else-
where.42 Following an established procedure,43
plasma-purified C3 was converted into the thioester-
hydrolyzed form C3(H2O) by incubating C3 in water
(37C, 2 h). Remaining, unconverted C3 was
removed by cation-exchange chromatrography
[MonoS 5/50 (1 mL)] (GE Healthcare); C3(H2O)
eluted off at  600 mM NaCl while C3 elutes earlier
in the gradient. Fractions containing C3(H2O) were
combined and dialyzed into PBS overnight.
To label the free thiol in C3(H2O), and simulta-
neously convert C3(H2O) into C3b, C3(H2O) (350 lg/mL
Figure 5. Possible flexibility within C3b/FH1-4 complex.
Upper cartoon: Summarized (as in Fig. 1) are positions of
CCP-3 and CCP-4 cysteine substitutions (in FH1-4) and of
Cys988 (in C3b) within the crystal structure of the complex
(plus possible positions of FH CCPs 5–7). Lower caroon:
Alternative relative positions of CCP 4 and TED could
explain the discrepancies between distance measurements
in the crystal and in the fluid phase. [Color figure can be
viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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in 400 lL), was labeled with Ax488 or Ax647 (400
lM) in the presence of 10 mM ethylenediaminetetra-
acetic acid (EDTA) and 8 lg cobra venom factor Bb
C3 convertase. This convertase converts C3(H2O)
into C3b and is used instead of the alternative path-
way convertase. The reaction was incubated (2 h,
room temperature, in the dark) then dialyzed into
PBS/0.05% (v/v) TWEEN-20 (BioRad) (i.e., PBS-T-
0.05) overnight. Size-exclusion chromatography
(Superdex 16/60 S300 (GE Healthcare) in PBS-T-
0.05) was performed to remove any C3b dimers from
the labeled C3b (C3bAx488 or C3bAx647).
To measure biological activity of FH1-4 con-
structs, an endpoint fluid-phase cofactor assay was
performed. For the assay, in 30 lL, 4 lg FI, and 10
lg C3b (equimolar at  2 lM) were mixed with 5 lg
FH (final concentration 1 lM) for the positive-con-
trol reaction. The negative control was prepared
similarly, but substituting FH with PBS. Wild-type
and mutant FH1-4 (0.9 lg in PBS, final concentra-
tion 1 lM) were prepared in the same way. The reac-
tion volume was finally made up to 30 lL using
PBS. The reaction mix was then vortexed and incu-
bated in a water bath (37C, 15 min). An aliquot of
2 reducing SDS buffer was added to stop the reac-
tion prior to analysis by SDS-PAGE.
Fluorescence lifetime measurements were car-
ried out in PBS. Time-correlated single photon
counting was used. Protein concentrations were ei-
ther: 33 lM for fH1-4Ax555 and 400 nM for
C3bAx488; or 400 nM for fH1-4Ax555, and 33 lM for
C3bAx647. The excitation source was the second
harmonic of the pulse-picked output of a Ti-Sap-
phire femtosecond laser system (Coherent, 10 W
Verdi, and Mira Ti-Sapphire), consisting of pulses
of  200 fs at 4.75 MHz repetition rate, with 465
nm wavelength. Fluorescence decays were meas-
ured in an Edinburgh Instruments spectrometer
equipped with TCC900 photon-counting electronics.
The emission from the sample was collected or-
thogonal to the excitation direction through a po-
larizer set at the magic angle with respect to the
vertically polarized excitation. The fluorescence
was passed through a monochromator (bandpass,
10 nm) and detected at 520 nm (Ax488 donor
emission) or 570 nm (Ax555 donor emission) by a
Hamamatsu Microchannel Plate Photomultiplier
(R3809U-50). The instrument response of the sys-
tem, measured using a Ludox scatterer, was  70
ps, full-width, half-maximum.
Fluorescence decay curves were analyzed using
an iterative reconvolution method, assuming a mul-
tiexponential decay function [Eq. (1)], employing
Edinburgh Instruments FAST software. To deter-
mine the number of exponential terms required to
fit the decay data, the quality of the fit was judged
on the basis of the reduced chi-squared statistic, v2,
and the randomness of the residuals. For our experi-
mental system, typically, we find that v2 <1.2 indi-
cates an acceptable fit.
IðtÞ ¼
Xn
i¼1
Ai exp
t
si
 
þ B (1)
where Ai and si are the fractional amplitude and flu-
orescence lifetime, respectively, of the ith decay com-
ponent (the value of Ai gives the fractional
population of the fluorescent species with lifetime
si); and B is the background count (the dark count of
the detector).
The average lifetime, sav, as defined in Eq. (2)
was used to calculate the FRET efficiency, Eav, [Eq.
(3)]. The average lifetime is proportional to the
quantum yield, /
sav ¼
Pn
i¼1
Aisi
Pn
i¼1
Ai
/ / (2)
Eav ¼ 1 s
DA
av
sDav
(3)
where sDAav and s
D
av are the average fluorescence life-
times of the donor, in the presence and absence of
the acceptor, respectively.
The energy transfer efficiency is related to the
average distance, R, between donor and acceptor,
according to Eq. (4).
Eav ¼ 1
1þ RR0
 6 (4)
where R0 is the Fo¨rster distance, at which the
energy transfer efficiency ¼ 0.5.
The Fo¨rster distance depends on the sixth root
of the quantum yield of the donor, /D.
R0 / /1=6D (5)
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